A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder

[1] Berlim MT(2013)Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: A meta-analysis of randomized, double-blind and sham-controlled trials Neuropsychopharmacology 38 543-551

[2] Van den Eynde F(2015)The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic review Neuropsychobiology 71 125-139

[3] Daskalakis ZJ(2015)Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial World Psych 14 464-473

[4] Serafini G(2016)The clinical TMS society consensus review and treatment recommendation for TMS therapy for major depressive disorder Brain Stimulation 9 336-346

[5] Pompili M(1994)Medication resistance, response to ECT, and prevention of relapse Psychiatr Ann 2495 228-231

[6] Murri MB(2006)Star*D study team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression NEJM 354 1231-1242

[7] Respiro M(2009)Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial Neuropsychopharmacology 34 522-534

[8] Ghio L(2000)Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression Jrl Clin Psychopharmacol 20 483-487

[9] Girardi P(2006)Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation Jrl Neuropsychopharm 9 641-654

[10] Lefkovitz Y(2007)Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psych 62 1208-1216

[1] Berlim MT(2013)Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: A meta-analysis of randomized, double-blind and sham-controlled trials Neuropsychopharmacology 38 543-551

[2] Van den Eynde F(2015)The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic review Neuropsychobiology 71 125-139

[3] Daskalakis ZJ(2015)Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial World Psych 14 464-473

[4] Serafini G(2016)The clinical TMS society consensus review and treatment recommendation for TMS therapy for major depressive disorder Brain Stimulation 9 336-346

[5] Pompili M(1994)Medication resistance, response to ECT, and prevention of relapse Psychiatr Ann 2495 228-231

[6] Murri MB(2006)Star*D study team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression NEJM 354 1231-1242

[7] Respiro M(2009)Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial Neuropsychopharmacology 34 522-534

[8] Ghio L(2000)Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression Jrl Clin Psychopharmacol 20 483-487

[9] Girardi P(2006)Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation Jrl Neuropsychopharm 9 641-654

[10] Lefkovitz Y(2007)Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psych 62 1208-1216